Xeris Biopharma Holdings (XERS) Deferred Taxes (2023 - 2024)
Xeris Biopharma Holdings (XERS) reported Deferred Taxes of -$3.3 million for Q3 2024, down 592.44% on a YoY basis from $675000.0 in Q4 2023, and down 543.79% quarter-over-quarter from $749000.0 in Q2 2024.
Xeris Biopharma Holdings (XERS) Deferred Taxes (2023 - 2024) Analysis & Trends
Xeris Biopharma Holdings has reported Deferred Taxes for 2 years, with the latest figure at -$3.3 million in Q3 2024.
- For the quarter ending Q3 2024, Deferred Taxes fell 592.44% year-over-year to -$3.3 million; the trailing twelve-month figure through Jun 2025 stood at -$3.3 million (down 789.63% YoY), and the FY2024 full-year result was -$2.3 million, down 81.59% from the prior year.
- Deferred Taxes for Q3 2024 stood at -$3.3 million, down from $749000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $749000.0 in Q2 2024, with the low at -$3.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -22.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 34.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 25.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14,341.73 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -61.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -8.79 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -13.98 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 19.33 Mn |
| 10 | Xeris Biopharma Holdings | 1.11 Bn | 994.95 Mn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | -1.25 Mn |
| Sep 30, 2023 | 675,000.00 |
| Jun 30, 2023 | -675,000.00 |